Bruix J - Search Results

1

Akt-mediated foxo1 inhibition is required for liver regeneration.

Pauta M, Rotllan N, Fernández-Hernando A, Langhi C, Ribera J, Lu M, Boix L, Bruix J, Jimenez W, Suárez Y, Ford DA, Baldán A, Birnbaum MJ, Morales-Ruiz M, Fernández-Hernando C. Pauta M, et al. Among authors: bruix j. Hepatology. 2016 May;63(5):1660-74. doi: 10.1002/hep.28286. Epub 2015 Dec 18. Hepatology. 2016. PMID: 26473496 Free PMC article.

2

p27(Kip1) is an independent predictor of recurrence after surgical resection in patients with small hepatocellular carcinoma.

Armengol C, Boix L, Bachs O, Solé M, Fuster J, Sala M, Llovet JM, Rodés J, Bruix J. Armengol C, et al. Among authors: bruix j. J Hepatol. 2003 May;38(5):591-7. doi: 10.1016/s0168-8278(03)00025-4. J Hepatol. 2003. PMID: 12713869

3

MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: an explant correlation.

Burrel M, Llovet JM, Ayuso C, Iglesias C, Sala M, Miquel R, Caralt T, Ayuso JR, Solé M, Sanchez M, Brú C, Bruix J; Barcelona Clínic Liver Cancer Group. Burrel M, et al. Among authors: bruix j. Hepatology. 2003 Oct;38(4):1034-42. doi: 10.1053/jhep.2003.50409. Hepatology. 2003. PMID: 14512891

4

Hepatitis C virus and liver disease: global transcriptional profiling and identification of potential markers.

Smith MW, Yue ZN, Korth MJ, Do HA, Boix L, Fausto N, Bruix J, Carithers RL Jr, Katze MG. Smith MW, et al. Among authors: bruix j. Hepatology. 2003 Dec;38(6):1458-67. doi: 10.1016/j.hep.2003.09.024. Hepatology. 2003. PMID: 14647057

5

Orthotopic implantation of human hepatocellular carcinoma in mice: analysis of tumor progression and establishment of the BCLC-9 cell line.

Armengol C, Tarafa G, Boix L, Solé M, Queralt R, Costa D, Bachs O, Bruix J, Capellá G. Armengol C, et al. Among authors: bruix j. Clin Cancer Res. 2004 Mar 15;10(6):2150-7. doi: 10.1158/1078-0432.ccr-03-1028. Clin Cancer Res. 2004. PMID: 15041736

6

Focus on hepatocellular carcinoma.

Bruix J, Boix L, Sala M, Llovet JM. Bruix J, et al. Cancer Cell. 2004 Mar;5(3):215-9. doi: 10.1016/s1535-6108(04)00058-3. Cancer Cell. 2004. PMID: 15050913 Free article. Review. No abstract available.

7

Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma.

Kremer-Tal S, Reeves HL, Narla G, Thung SN, Schwartz M, Difeo A, Katz A, Bruix J, Bioulac-Sage P, Martignetti JA, Friedman SL. Kremer-Tal S, et al. Among authors: bruix j. Hepatology. 2004 Nov;40(5):1047-52. doi: 10.1002/hep.20460. Hepatology. 2004. PMID: 15486921

8

Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma.

Sala M, Llovet JM, Vilana R, Bianchi L, Solé M, Ayuso C, Brú C, Bruix J; Barcelona Clínic Liver Cancer Group. Sala M, et al. Among authors: bruix j. Hepatology. 2004 Dec;40(6):1352-60. doi: 10.1002/hep.20465. Hepatology. 2004. PMID: 15565564

9

Management of hepatocellular carcinoma.

Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Bruix J, et al. Hepatology. 2005 Nov;42(5):1208-36. doi: 10.1002/hep.20933. Hepatology. 2005. PMID: 16250051 No abstract available.

10

Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.

Forner A, Vilana R, Ayuso C, Bianchi L, Solé M, Ayuso JR, Boix L, Sala M, Varela M, Llovet JM, Brú C, Bruix J. Forner A, et al. Among authors: bruix j. Hepatology. 2008 Jan;47(1):97-104. doi: 10.1002/hep.21966. Hepatology. 2008. PMID: 18069697 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

384 results

Search Page

Filters